MediPharm Labs (LABS) Competitors C$0.08 +0.01 (+7.14%) As of 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. CRDL, MDP, TGOD, NINE, DB, WMD, HEXO, VIR, ZOM, and METAShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Cardiol Therapeutics (CRDL), Medexus Pharmaceuticals (MDP), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Decibel Cannabis (DB), WeedMD (WMD), HEXO (HEXO), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), and Meta Growth (META). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. Its Competitors Cardiol Therapeutics Medexus Pharmaceuticals Green Organic Dutchman Delta 9 Cannabis Decibel Cannabis WeedMD HEXO Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) Meta Growth Cardiol Therapeutics (TSE:CRDL) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations. Which has better valuation and earnings, CRDL or LABS? MediPharm Labs has higher revenue and earnings than Cardiol Therapeutics. MediPharm Labs is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardiol TherapeuticsN/AN/A-C$42.93M-C$0.48-3.02MediPharm LabsC$44.45M0.71-C$12.05M-C$0.02-3.75 Do institutionals and insiders believe in CRDL or LABS? 0.8% of Cardiol Therapeutics shares are held by institutional investors. Comparatively, 0.3% of MediPharm Labs shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Comparatively, 4.5% of MediPharm Labs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is CRDL or LABS more profitable? Cardiol Therapeutics has a net margin of 0.00% compared to MediPharm Labs' net margin of -30.56%. MediPharm Labs' return on equity of -24.41% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cardiol TherapeuticsN/A -195.07% -54.15% MediPharm Labs -30.56%-24.41%-7.17% Does the media prefer CRDL or LABS? In the previous week, Cardiol Therapeutics' average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score. Company Overall Sentiment Cardiol Therapeutics Neutral MediPharm Labs Neutral Which has more risk & volatility, CRDL or LABS? Cardiol Therapeutics has a beta of 0.954809, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of 0.431007, indicating that its stock price is 57% less volatile than the S&P 500. SummaryCardiol Therapeutics and MediPharm Labs tied by winning 5 of the 10 factors compared between the two stocks. Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$31.56MC$1.69BC$5.81BC$9.34BDividend YieldN/A2.93%6.67%6.52%P/E Ratio-3.7565.3175.7525.66Price / Sales0.711,377.37454.639.44Price / Cash1.3010.3725.7083.29Price / Book0.6811.5011.505.41Net Income-C$12.05MC$20.70BC$3.28BC$301.20M7 Day PerformanceN/A0.06%1.30%1.97%1 Month PerformanceN/A4.72%11.26%8.08%1 Year PerformanceN/A4.83%59.56%41.02% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.08+7.1%N/A+16.7%C$31.56MC$44.45M-3.75130CRDLCardiol TherapeuticsN/AC$1.49-2.0%N/A-41.0%C$124.76MN/A-3.1020MDPMedexus Pharmaceuticals1.9568 of 5 starsC$3.10+1.6%C$5.49+77.0%+16.4%C$100MC$105.66M155.0098TGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Gap UpDBDecibel CannabisN/AC$0.13-3.8%N/A+92.3%C$72.09MC$100.50M4.1783,000WMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpHEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580News CoverageGap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap DownMETAMeta GrowthN/AC$0.14flatN/A+0.0%C$33.14MC$60.96M-0.6686,500News CoverageGap Down Related Companies and Tools Related Companies Cardiol Therapeutics Competitors Medexus Pharmaceuticals Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors Decibel Cannabis Competitors WeedMD Competitors HEXO Competitors Viridium Pacific Group Competitors Zomedica Pharmaceuticals Corp. (ZOM.V) Competitors Meta Growth Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABS Stock Alerts